STOCK TITAN

Oracle (ORCL) Form 4 Filings

ORCL NYSE

Here are the Form 4 insider transactions from Oracle Corp (ORCL) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ORCL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ORCL filings page.

Rhea-AI Summary

Maria Smith, Oracle's EVP, Chief Accounting Officer, reported converting 8,926 restricted stock units into 8,926 common shares on October 23, 2026. The transaction also lists 4,673 shares withheld for tax liability upon vesting, at a reported $125.54 per share. Her directly held restricted stock unit position was 26,780 following the transaction.

Rhea-AI Summary

Oracle Corp (ORCL) Vice Chairman Jeffrey Henley reported the conversion of 8,033 restricted stock units on October 23, 2026. A trust acquired 8,033 common shares, and a trust withheld 3,529 shares for tax liability upon vesting. His reported remaining restricted stock unit position was 24,102 units. Indirect holdings reported included 745,000 shares by a GRAT and 490,333 shares by the Henley Community Property Trust. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

Oracle Corp. (ORCL) Chief Executive Officer Safra Catz exercised 8,033 restricted stock units on October 23, 2026, acquiring 8,033 common shares. At vesting, 2,550 shares were withheld for tax liability, reported at $125.54 per share. The reported position following the exercise was 24,102 restricted stock units; each unit represents the right to receive one common share at settlement. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

Oracle's EVP and Chief Legal Officer Stuart Levey reported 12,497 common shares acquired through settlement of restricted stock units on October 23, 2026, and 6,130 shares withheld for tax liability upon vesting. He also reported 479.117 dividend equivalents accrued with respect to earned restricted stock units granted November 5, 2022, which he elected to defer. Oracle's closing stock price of $126.16 on October 23, 2026, was used to calculate the dividend equivalents.

Rhea-AI Summary

Oracle Corp. granted Chief Executive Officer Michael D. Sicilia 446,197 restricted stock units on October 15, 2026. Each unit represents the right to receive one share of common stock at settlement. The units vest in installments: 40% on October 15, 2027, 30% on October 15, 2028, 20% on October 15, 2029, and 5% on each of October 15, 2030 and October 15, 2031, subject to his continued employment through each applicable vesting date.

Rhea-AI Summary

Oracle Corporation (ORCL) EVP, Chief Accounting Officer Maria Smith was awarded 66,930 restricted stock units on October 15, 2026, bringing her reported direct RSU holdings to 66,930. Each unit represents the right to receive one share of common stock at settlement.

Rhea-AI Summary

Oracle Corp. Chief Financial Officer Hilary B. Maxson received an award of 89,240 restricted stock units on October 15, 2026. The units vest as to 25% on October 15, 2027, and 6.25% of the total original number of units vests on the same day of every third month thereafter, subject to continued employment through each applicable vesting date.

Rhea-AI Summary

Oracle Corp. Chief Executive Officer Clayton M. Magouyrk received an award of 446,197 restricted stock units on October 15, 2026; the reported resulting position was 446,197 units. Each unit represents the right to receive one common share at settlement. The units vest 40% on October 15, 2027, 30% on October 15, 2028, 20% on October 15, 2029, 5% on October 15, 2030, and 5% on October 15, 2031, subject to continued employment through each applicable vesting date.

Rhea-AI Summary

Oracle Corporation granted EVP, Chief Legal Officer Stuart Levey 104,113 restricted stock units on October 15, 2026. Each unit represents the right to receive one share of common stock at settlement. The units vest as to 25% on October 15, 2027, then 6.25% of the original award on the same day of every third month thereafter, subject to his continued employment through each applicable vesting date.

Rhea-AI Summary

Oracle Corp. reported that Mark Hura, its President, Global Field Operations, acquired 237,972 restricted stock units on October 15, 2026. Each unit represents the right to receive one common share at settlement. His reported resulting position was 237,972 restricted stock units, held directly. The award is a derivative security.

Rhea-AI Summary

Oracle Corp. reported a direct grant of 66,930 restricted stock units to Vice Chairman and director Jeffrey Henley on October 15, 2026. Each unit represents the right to receive one share of common stock at settlement. 25% vest on October 15, 2027, and 6.25% of the total original units vest every third month thereafter, subject to continued employment through each applicable vesting date.

Rhea-AI Summary

Oracle (ORCL) Executive Chairman and Chief Technology Officer Lawrence Joseph Ellison received a grant of 223,099 restricted stock units on October 15, 2026. Each unit represents the right to receive one common share at settlement. The units vest 40% on October 15, 2027, 30% on October 15, 2028, 20% on October 15, 2029, and 5% on each of October 15, 2030 and October 15, 2031, subject to continued employment through each applicable vesting date.

Rhea-AI Summary

Safra Catz, Oracle's Chief Executive Officer, received a direct award of 66,930 restricted stock units on October 15, 2026. Each unit represents the right to receive one share of common stock at settlement. The units vest 25% on October 15, 2027, then 6.25% of the total original award every third month thereafter, subject to Safra Catz's continued employment through each applicable vesting date.

Rhea-AI Summary

Oracle Corp. director Stephen H. Rusckowski reported that The Stephen H. Rusckowski Living Trust purchased 25,000 common shares on September 29, 2026, at a reported weighted-average price of $139.3520 per share. After the purchase, the trust held 25,390 shares indirectly, and Rusckowski held 60 shares directly. No Rule 10b5-1 plan was reported for the purchase.

Rhea-AI Summary

Oracle Corp. EVP, Chief Accounting Officer Maria Smith reported conversion of 5,506 restricted stock units into 5,506 common shares on September 20, 2026, and conversion of 11,934 restricted stock units into 11,934 common shares on September 19, 2026. On September 21, 2026, 6,230 and 2,875 common shares were withheld for tax liability upon vesting, each at $147.61 per share. She sold 2,631 common shares at $151.70 per share on September 22, 2026. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

Oracle Corp (ORCL) Chief Executive Officer Michael D. Sicilia reported converting 73,411 restricted stock units into common shares on September 20, 2026, and 35,802 on September 19. On September 21, 2026, 17,311 and 35,495 shares were withheld for tax liability upon vesting, at $147.61 per share. He sold 22,562 common shares on September 22, 2026, at $151.59 per share, pursuant to a Rule 10b5-1 plan adopted on December 24, 2025. A September 19, 2026 holding entry lists 2,655 common shares held indirectly by his spouse.

Rhea-AI Summary

Oracle Corporation Chief Executive Officer Clayton M. Magouyrk reported conversion/exercise of 41,769 restricted stock units into the same number of common shares on September 19, 2026, and 88,093 restricted stock units into the same number of common shares on September 20, 2026. On September 21, 2026, 16,437 and 34,665 common shares were withheld for tax liability, each reported at $147.61 per share. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

At ORCL, EVP, Chief Legal Officer Levey Stuart converted 20,885 restricted stock units into 20,885 common shares on September 19, 2026, with 41,769 restricted stock units reported following the conversion. On September 21, 2026, 10,245 common shares were withheld for tax liability upon vesting of restricted stock units at $147.61 per share. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

Mark Hura, Oracle's President of Global Field Operations, acquired 19,393 common shares on September 19, 2026, and 47,717 common shares on September 20, 2026, through conversion of restricted stock units. On September 21, 2026, 8,456 and 20,805 common shares were withheld for tax liability upon vesting, at $147.61 per share. The restricted stock units vest in four equal annual installments, beginning on the first anniversary of the grant date. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

Oracle Corp. Vice Chairman Jeffrey Henley reported 33,035 restricted stock units converted into common stock on September 20, 2026, and 13,426 restricted stock units converted on September 19, 2026; the common shares were acquired indirectly by trust on each date. On September 21, 2026, trust-held shares of 5,884 and 14,462 were withheld for tax liability upon vesting, at a reported $147.61 per share. Separate indirect holdings reported September 19 included 745,000 shares by a GRAT and 490,333 shares by Henley Community Property Trust.

Rhea-AI Summary

ORACLE CORP (ORCL) executive Maria Smith, EVP and Chief Accounting Officer, reported the vesting and settlement of 13,168 restricted stock units into an equal number of shares of common stock on September 15, 2026. Of these shares, 6,874 were withheld to satisfy tax liability, and she continues to hold 13,169 restricted stock units directly. The company states that these restricted stock units vest in four equal annual installments, and no Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

ORACLE CORP (ORCL) Chief Executive Officer Michael D. Sicilia reported several equity transactions. On September 16, 2026, he sold 10,882 shares of common stock at $139.94 per share pursuant to a Rule 10b5-1 Plan adopted on December 24, 2025. On September 15, 2026, 52,673 restricted stock units converted into the same number of common shares, and 25,468 shares were withheld to cover tax liability on vesting. He also reports 2,655 shares of common stock held indirectly by his spouse and 52,674 restricted stock units remaining after these transactions.

Rhea-AI Summary

Oracle Corp (ORCL) reported that its Chief Executive Officer, Clayton M. Magouyrk, had restricted stock units vest on September 15, 2026, converting 61,452 RSUs into an equal number of common shares. In connection with this vesting, 24,182 shares were withheld to pay tax liabilities, and the filing shows 61,453 restricted stock units remaining outstanding. No transactions were made under a Rule 10b5-1 trading plan.

Rhea-AI Summary

ORACLE CORP (ORCL) reported that executive vice president and chief legal officer Stuart Levey exercised and settled 26,337 Restricted Stock Units into an equal number of Oracle common shares on September 15, 2026. Of these, 11,883 shares were withheld to satisfy tax liability at $144.79 per share; no Rule 10b5-1 trading plan is indicated.

Rhea-AI Summary

ORACLE CORP (ORCL) reported that Mark Hura, President, Global Field Operations, had restricted stock units vest on September 15, 2026, resulting in the issuance of 28,531 shares of common stock. Of these, 12,440 shares were withheld at $144.79 per share to cover tax liability, and 28,532 restricted stock units remain outstanding, vesting in four equal annual installments. No Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

ORACLE CORP (ORCL) director and vice chairman Jeffrey Henley reported the vesting and conversion of 19,752 Restricted Stock Units into an equal number of shares of common stock on September 15, 2026, held indirectly by a trust. In connection with this vesting, 8,635 shares were withheld by the trust to pay tax liabilities at $144.79 per share. Following these transactions, Henley also reports indirect holdings of 745,000 shares of common stock held by a GRAT and 490,333 shares held by the Henley Community Property Trust; no Rule 10b5-1 plan is reported.

Rhea-AI Summary

Oracle executive Stuart Levey, EVP and Chief Legal Officer, received an award of 523.382 restricted stock unit dividend equivalents on July 24, 2026. These relate to earned restricted stock units granted on November 5, 2022 and were calculated using Oracle’s $114.99 closing stock price on that dividend payment date.

After this compensation-related acquisition, Levey directly holds 160,364.685 Oracle common stock equivalents.

Rhea-AI Summary

Oracle Corp vice chairman Jeffrey Henley reported an exercise-and-sell transaction in Oracle common stock. On June 24, 2026, he exercised stock options to acquire 400,000 shares at an exercise price of $40.93 per share pursuant to a Rule 10b5-1 plan adopted on January 2, 2026.

The same day, he sold 400,000 shares in multiple open-market trades at weighted average prices ranging from about $155.50 to $165.57, also under that pre-arranged Rule 10b5-1 plan. After these transactions, he held 325,031 Oracle shares directly.

Henley also reported significant indirect ownership, including 490,333 Oracle shares held by the Henley Community Property Trust, 455,910 shares held by a trust, and 745,000 shares held by a GRAT, showing that a large portion of his overall exposure remains in indirect vehicles.

Rhea-AI Summary

RUSCKOWSKI STEPHEN H reported acquisition or exercise transactions in this Form 4 filing.

Oracle Corp director Stephen H. Rusckowski received a grant of 1,550 restricted stock units. Each unit represents the right to receive one share of Oracle common stock at settlement. The restricted stock units vest 100% on the first anniversary of the grant date.

After this compensation-related award, Rusckowski holds 1,550 restricted stock units directly, with no open-market purchases or sales reported in this filing.

Rhea-AI Summary

Oracle director Charles W. Moorman reported routine equity compensation activity. He exercised 2,114 restricted stock units, receiving the same number of Oracle common shares at a stated price of $0.0000 per share, and now holds 40,689 common shares directly.

He also received a new grant of 1,550 restricted stock units, each representing one future share of common stock, which vest 100% on the first anniversary of the grant date. In addition, he is shown with 52,954 common shares held indirectly through multiple family trusts, reflecting indirect ownership rather than a new market trade.

Rhea-AI Summary

Mihaljevic Tomislav reported acquisition or exercise transactions in this Form 4 filing.

Oracle Corp director Tomislav Mihaljevic received a grant of 1,550 restricted stock units (RSUs). Each RSU represents the right to receive one share of Oracle common stock at settlement. The RSUs vest 100% on the first anniversary of the grant date, and this award brings his reported RSU holdings to 1,550 units held directly.

Rhea-AI Summary

Oracle director Rona Fairhead reported routine equity compensation activity involving restricted stock units. On May 31, 2026, 2,114 restricted stock units were converted into 2,114 shares of Oracle common stock, and 58 shares were withheld at $225.78 per share to cover tax liabilities on vesting.

She also received a grant of 1,550 new restricted stock units, which vest 100% on the first anniversary of the grant date. Following these transactions, Fairhead directly holds 24,166 shares of Oracle common stock, in addition to indirect holdings for three children of 3,861, 3,720, and 3,694 shares, respectively.

Rhea-AI Summary

Oracle Corp director Bruce R. Chizen reported routine equity compensation activity with no open-market trades. He exercised 2,114 restricted stock units into 2,114 shares of common stock, increasing his directly held common stock to 71,056 shares. He also received a new grant of 1,550 restricted stock units, each representing the right to receive one share of common stock at settlement and scheduled to vest 100% on the first anniversary of the grant date. In addition, 13,169 shares of common stock are reported as held indirectly through a trust.

Rhea-AI Summary

Oracle director Michael J. Boskin reported routine equity compensation activity. He exercised restricted stock units covering 2,114 shares of Oracle common stock, bringing his directly held common stock to 97,558 shares. He also received a new grant of 1,550 restricted stock units, which each convert into one share and vest 100% on the first anniversary of the grant date. In addition, 1,000 shares of common stock are reported as held indirectly through his spouse.

Rhea-AI Summary

Oracle Corp director Jeffrey Berg reported routine equity compensation changes. He exercised 2,114 restricted stock units, which converted into 2,114 shares of Oracle common stock held indirectly through The Berg Family Trust, bringing that trust’s indirect common stock holdings to 154,113 shares.

He also received a new grant of 1,550 restricted stock units, all held directly, each representing one future share of common stock at settlement. The filing notes an additional indirect holding of 1,450 common shares held by his spouse and includes a correction to previously reported indirect beneficial ownership from an earlier Form 4.

Rhea-AI Summary

Oracle Corp director Ablo Awo reported routine equity compensation activity involving restricted stock units. On May 31, 2026, 2,114 restricted stock units were exercised into the same number of common shares, and 80 shares of common stock were withheld at $225.78 per share to cover tax obligations.

On the same date, Awo also received a new grant of 1,550 restricted stock units, each representing the right to receive one share of Oracle common stock at settlement. These units vest 100% on the first anniversary of the grant date, reflecting standard time-based vesting rather than an open-market transaction.

Rhea-AI Summary

Oracle Corporation Chief Financial Officer Hilary B. Maxson received new equity awards. On May 5, 2026, she was granted 56,111 restricted stock units and stock options on 224,441 shares of common stock at an exercise price of $185.35 per share.

The stock options vest 40% on May 5, 2027, 30% on May 5, 2028, 20% on May 5, 2029, and 10% on May 5, 2030, and expire on May 5, 2036, subject to continued employment through each vesting date. The restricted stock units follow the same 40/30/20/10 vesting schedule and each unit represents the right to receive one share of common stock at settlement.

Rhea-AI Summary

Oracle Corporation executive vice president and chief legal officer Stuart Levey acquired 346.321 restricted stock units in the form of dividend equivalents tied to previously earned RSUs granted on November 5, 2022. The dividend equivalents were calculated using Oracle’s closing stock price of $173.28 on April 24, 2026, and increase his directly held equity-based position to 159,841.303 units of common-stock-settled awards. This is a compensation-related grant, not an open‑market trade.

Rhea-AI Summary

ORACLE CORP executive vice president and chief legal officer Stuart Levey reported an open-market sale of 15,000 shares of Oracle common stock at an average price of $176.19 per share. After this transaction, he directly holds 3,429 shares. The sale was executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on January 13, 2026, indicating it was scheduled in advance rather than timed discretionarily.

Rhea-AI Summary

Oracle Corp vice chairman Jeffrey Henley reported an internal restructuring of his indirect Oracle common stock holdings. On April 16, 2026, 745,000 shares were transferred from the Jeffrey & Judy Henley 1989 Trust to a newly created grantor retained annuity trust, both entities associated with him as trustee, with no cash consideration. Following the transactions, indirect holdings reported include 455,910 shares by the 1989 Trust, 745,000 shares by the new GRAT, and 490,333 shares by the Henley Community Property Trust, reflecting estate-planning movements rather than open‑market trading.

Rhea-AI Summary

Oracle Corp director and vice chairman Jeffrey Henley reported indirect share transfers involving family trusts. On March 30, 2026, a grantor retained annuity trust (GRAT) associated with him made a bona fide gift of 16,810 Oracle common shares. The same day, 128,304 shares were moved from his 2024 GRAT to the Henley Community Property Trust, which he views as a change in the form of beneficial ownership under Rule 16a-13.

After these moves, filings show 1,200,910 Oracle shares held indirectly by a trust and 490,333 shares held indirectly by the Henley Community Property Trust. The activity reflects estate and ownership structuring rather than open‑market buying or selling.

Rhea-AI Summary

Oracle Corp Chief Executive Officer Clayton M. Magouyrk reported an open-market sale of 10,000 shares of Oracle common stock. The transaction occurred on February 9, 2026 at a weighted average price of $155.2318 per share, based on multiple trades between $155.23 and $155.28.

After this sale, Magouyrk directly owns 134,030 Oracle shares. The filing notes that detailed trade-by-trade price and share information is available upon request to Oracle, the SEC staff, or any Oracle shareholder.

Rhea-AI Summary

Oracle Corporation executive Stuart Levey reported a routine equity accrual related to his compensation. On 01/23/2026, he received 337.783 restricted stock units as an "A"-coded acquisition. These units represent dividend equivalents accrued on earned restricted stock units originally granted on November 5, 2022, which he has elected to defer. The number of dividend equivalents was calculated using Oracle's closing stock price of $177.16 on the dividend payment date. Following this transaction, Levey beneficially owns 159,494.982 derivative securities in the form of restricted stock units, held directly.

Rhea-AI Summary

Oracle Corp executive Douglas A. Kehring, EVP and Principal Financial Officer, reported selling 35,000 shares of Oracle common stock on January 15, 2026 at a price of $194.89 per share. The sale was made pursuant to a Rule 10b5-1 trading plan that was adopted on October 9, 2025, which allows pre-arranged trading according to preset terms.

Following this transaction, Kehring reports 33,638 shares of Oracle common stock held directly. He also reports an additional 2,157.514 units of Oracle common stock indirectly through the company’s 401(k) plan, where his interest is represented by units in a common stock fund rather than individual shares.

Rhea-AI Summary

Oracle Corp executive Mark Hura reported two recent transactions in Oracle stock. On 12/22/2025, he made a bona fide gift of 5,000 shares of common stock to a donor advisory fund. Following that gift, he held 249,077 shares directly. On 12/24/2025, he sold 15,000 shares of Oracle common stock in open-market trades at a weighted average price of $196.8876 per share, with individual trades ranging from $196.87 to $196.93. After this sale, he directly owned 234,077 Oracle shares. Hura is identified as an officer of Oracle, serving as President, Global Field Operations.

Rhea-AI Summary

Oracle Corporation insider Jeffrey Henley, a director and Vice Chairman, reported a change in how he holds some of his Oracle common stock. On December 23, 2025, he transferred 199,071 shares of common stock from his family trust to the Jeffrey & Judy Henley 1989 Trust. The filing states that he believes this transfer is a change in the form of beneficial ownership that is exempt under Rule 16a-13 of the Securities Exchange Act of 1934.

After the transaction, Henley reported indirect beneficial ownership of 1,200,910 shares by trust, 145,114 shares by a GRAT, and 362,029 shares by the Henley Community Property Trust. The reported transaction price is listed as $0, reflecting that this was a restructuring of ownership between related trusts rather than an open-market trade.

Rhea-AI Summary

Oracle Corp director Naomi O. Seligman reported selling 2,223 shares of Oracle common stock at a price of $196.61 per share on 12/23/2025. After this transaction, she beneficially owned 25,596 shares directly, 6,000 shares indirectly through her spouse, and 14,414 shares indirectly through a trust. The filing indicates this was a routine insider transaction reported by a single reporting person.

Form 4
Rhea-AI Summary

Oracle Corp's chief executive officer, Clayton M. Magouyrk, reported a sale of company stock. On 12/19/2025, he sold 10,000 shares of Oracle common stock in an open market transaction at a weighted average price of $192.5152 per share. The filing notes that the trade was executed in multiple transactions at prices ranging from $192.48 to $192.625, with the reported price reflecting the weighted average.

Following this sale, Magouyrk beneficially owned 144,030 shares of Oracle common stock in direct ownership. The reporting person has undertaken to provide full trade details, including the number of shares and specific prices for each trade, to the SEC staff, Oracle, or any Oracle security holder upon request.

Rhea-AI Summary

Oracle Corporation executive Maria Smith, EVP and Chief Accounting Officer, reported equity transactions in Oracle common stock. On 12/05/2025, 11,016 shares were acquired at an exercise or conversion price of $0 through the vesting and settlement of restricted stock units, increasing her directly held shares. On the same date, 5,740 shares were disposed of at $214.33 per share to cover tax withholding obligations related to the vesting. After these transactions, Smith directly beneficially owned 52,359 shares of Oracle common stock.

Rhea-AI Summary

Oracle Corporation (ORCL) director Stephen Rusckowski reported an equity award in the form of restricted stock units. On 11/18/2025, he received 793 restricted stock units, each representing the right to receive one share of Oracle common stock at settlement. The filing shows these derivative securities as owned directly, with an exercise price of $0.

The restricted stock units are scheduled to vest 100% on the first anniversary of the grant date, meaning all 793 units vest together after one year. This is a routine director equity grant intended to align the director’s interests with those of shareholders over time.